Global Benign Prostatic Hyperplasia (BPH) Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Date : Oct 2018

Formats :
Report Code : PMR103807879

Category : Pharmaceutical and Healthcare
No Of Pages : 130

Benign Prostatic Hyperplasia BPH Drugs Market

Urology is a branch of medicine that deals with the health of the urinary tract and reproductive tract in men and women. Urologic diseases or conditions include infection in the urinary tract, bladder control problems, kidney stones and prostate problems, among others. The prostate gland surrounds the urethra, the tube that carries urine from the bladder out of the body. Benign prostatic hyperplasia BPH is an enlarged prostate, which increases the size of the prostate gland. As the prostate gets enlarged, it may squeeze or partly block the urethra, resulting in significantly blocking urine flow. BPH is normal in the aging process of a male, caused by changes in hormone balance and cell-growth.



Scope of the Report:

This report focuses on the Benign Prostatic Hyperplasia BPH Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The increasing demand for Benign Prostatic Hyperplasia BPH Drugs drives the market. Three factors contributing to the growth of the global benign prostatic hyperplasia drugs market are growing geriatric male population, strong r&d and growing demand for alpha-blockers. The evolution of alpha-blockers therapy for BPH has focused on improving convenience and tolerability. Reversing signs and symptoms or preventing progression of the disease are the indications of treating BPH. Alpha-blockers are the most effective, least costly, and best tolerated of the drugs for relieving LUTS. Additionally, one driver in market is growing geriatric male population. The presence of a large population with BPH symptoms is expected to drive the market growth. The risk of BPH increases exponentially with the rise in the age of an individual. Approximately, 80% of men who reach 60 years and above have mild to strong symptoms of BPH. This disorder affects one in 38 individuals in the age group of 40-59 years; however, in the age group of 60-69 years, it affects one in 14 individuals. The BPH drugs market in the Americas accounted for the majority market share during 2016 and the market in this region is likely to experience a high growth rate during the estimated period. Factors such as the growing demand for urology-related disorders and the increasing rate of geriatric men population, will stimulate the demand for BPH drugs and fuel the market’s growth.

The worldwide market for Benign Prostatic Hyperplasia BPH Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new Planet Market Reports study.



Market Segment by Manufacturers, this report covers

Astellas Pharma

Eli Lilly

GlaxoSmithKline

Sanofi

ADC Therapeutics

Bayer HealthCare

Bristol-Myers Squibb

Valeant Pharmaceuticals

Endo Pharmaceuticals

Foresee Pharmaceuticals



Market Segment by Regions, regional analysis covers

North America United States, Canada and Mexico

Europe Germany, France, UK, Russia and Italy

Asia-Pacific China, Japan, Korea, India and Southeast Asia

South America Brazil, Argentina, Colombia etc.

Middle East and Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa



Market Segment by Type, covers

Alpha-Blocker

Phosphodiesterase Type-5 Inhibitors

5-Alpha-Reductase Inhibitors



Market Segment by Applications, can be divided into

Men

Women



There are 15 Chapters to deeply display the global Benign Prostatic Hyperplasia BPH Drugs market.

Chapter 1, to describe Benign Prostatic Hyperplasia BPH Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Benign Prostatic Hyperplasia BPH Drugs, with sales, revenue, and price of Benign Prostatic Hyperplasia BPH Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Benign Prostatic Hyperplasia BPH Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Benign Prostatic Hyperplasia BPH Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Benign Prostatic Hyperplasia BPH Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
Table of Contents



1 Market Overview

1.1 Benign Prostatic Hyperplasia BPH Drugs Introduction

1.2 Market Analysis by Type

1.2.1 Alpha-Blocker

1.2.2 Phosphodiesterase Type-5 Inhibitors

1.2.3 5-Alpha-Reductase Inhibitors

1.3 Market Analysis by Applications

1.3.1 Men

1.3.2 Women

1.4 Market Analysis by Regions

1.4.1 North America United States, Canada and Mexico

1.4.1.1 United States Market States and Outlook 2013-2023

1.4.1.2 Canada Market States and Outlook 2013-2023

1.4.1.3 Mexico Market States and Outlook 2013-2023

1.4.2 Europe Germany, France, UK, Russia and Italy

1.4.2.1 Germany Market States and Outlook 2013-2023

1.4.2.2 France Market States and Outlook 2013-2023

1.4.2.3 UK Market States and Outlook 2013-2023

1.4.2.4 Russia Market States and Outlook 2013-2023

1.4.2.5 Italy Market States and Outlook 2013-2023

1.4.3 Asia-Pacific China, Japan, Korea, India and Southeast Asia

1.4.3.1 China Market States and Outlook 2013-2023

1.4.3.2 Japan Market States and Outlook 2013-2023

1.4.3.3 Korea Market States and Outlook 2013-2023

1.4.3.4 India Market States and Outlook 2013-2023

1.4.3.5 Southeast Asia Market States and Outlook 2013-2023

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook 2013-2023

1.4.4.2 Egypt Market States and Outlook 2013-2023

1.4.4.3 Saudi Arabia Market States and Outlook 2013-2023

1.4.4.4 South Africa Market States and Outlook 2013-2023

1.4.4.5 Nigeria Market States and Outlook 2013-2023

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Astellas Pharma

2.1.1 Business Overview

2.1.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Astellas Pharma Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.2 Eli Lilly

2.2.1 Business Overview

2.2.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Eli Lilly Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.4 Sanofi

2.4.1 Business Overview

2.4.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Sanofi Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.5 ADC Therapeutics

2.5.1 Business Overview

2.5.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 ADC Therapeutics Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.6 Bayer HealthCare

2.6.1 Business Overview

2.6.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Bayer HealthCare Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.7 Bristol-Myers Squibb

2.7.1 Business Overview

2.7.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Bristol-Myers Squibb Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.8 Valeant Pharmaceuticals

2.8.1 Business Overview

2.8.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Valeant Pharmaceuticals Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.9 Endo Pharmaceuticals

2.9.1 Business Overview

2.9.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Endo Pharmaceuticals Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

2.10 Foresee Pharmaceuticals

2.10.1 Business Overview

2.10.2 Benign Prostatic Hyperplasia BPH Drugs Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Foresee Pharmaceuticals Benign Prostatic Hyperplasia BPH Drugs Sales, Price, Revenue, Gross Margin and Market Share 2016-2017

3 Global Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue, Market Share and Competition by Manufacturer 2016-2017

3.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Manufacturer 2016-2017

3.2 Global Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Manufacturer 2016-2017

3.3 Market Concentration Rate

3.3.1 Top 3 Benign Prostatic Hyperplasia BPH Drugs Manufacturer Market Share in 2017

3.3.2 Top 6 Benign Prostatic Hyperplasia BPH Drugs Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Benign Prostatic Hyperplasia BPH Drugs Market Analysis by Regions

4.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Regions

4.1.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Regions 2013-2018

4.1.2 Global Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Regions 2013-2018

4.2 North America Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

4.3 Europe Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

4.4 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

4.5 South America Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

4.6 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

5 North America Benign Prostatic Hyperplasia BPH Drugs by Countries

5.1 North America Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Countries

5.1.1 North America Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Countries 2013-2018

5.1.2 North America Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Countries 2013-2018

5.2 United States Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

5.3 Canada Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

5.4 Mexico Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

6 Europe Benign Prostatic Hyperplasia BPH Drugs by Countries

6.1 Europe Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Countries

6.1.1 Europe Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Countries 2013-2018

6.1.2 Europe Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Countries 2013-2018

6.2 Germany Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

6.3 UK Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

6.4 France Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

6.5 Russia Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

6.6 Italy Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

7 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs by Countries

7.1 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Countries 2013-2018

7.1.2 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Countries 2013-2018

7.2 China Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

7.3 Japan Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

7.4 Korea Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

7.5 India Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

7.6 Southeast Asia Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

8 South America Benign Prostatic Hyperplasia BPH Drugs by Countries

8.1 South America Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Countries

8.1.1 South America Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Countries 2013-2018

8.1.2 South America Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Countries 2013-2018

8.2 Brazil Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

8.3 Argentina Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

8.4 Colombia Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

9 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs by Countries

9.1 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Countries 2013-2018

9.1.2 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Countries 2013-2018

9.2 Saudi Arabia Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

9.3 UAE Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

9.4 Egypt Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

9.5 Nigeria Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

9.6 South Africa Benign Prostatic Hyperplasia BPH Drugs Sales and Growth Rate 2013-2018

10 Global Benign Prostatic Hyperplasia BPH Drugs Market Segment by Type

10.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Market Share by Type 2013-2018

10.1.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales and Market Share by Type 2013-2018

10.1.2 Global Benign Prostatic Hyperplasia BPH Drugs Revenue and Market Share by Type 2013-2018

10.2 Alpha-Blocker Sales Growth and Price

10.2.1 Global Alpha-Blocker Sales Growth 2013-2018

10.2.2 Global Alpha-Blocker Price 2013-2018

10.3 Phosphodiesterase Type-5 Inhibitors Sales Growth and Price

10.3.1 Global Phosphodiesterase Type-5 Inhibitors Sales Growth 2013-2018

10.3.2 Global Phosphodiesterase Type-5 Inhibitors Price 2013-2018

10.4 5-Alpha-Reductase Inhibitors Sales Growth and Price

10.4.1 Global 5-Alpha-Reductase Inhibitors Sales Growth 2013-2018

10.4.2 Global 5-Alpha-Reductase Inhibitors Price 2013-2018

11 Global Benign Prostatic Hyperplasia BPH Drugs Market Segment by Application

11.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales Market Share by Application 2013-2018

11.2 Men Sales Growth 2013-2018

11.3 Women Sales Growth 2013-2018

12 Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales, Revenue and Growth Rate 2018-2023

12.2 Benign Prostatic Hyperplasia BPH Drugs Market Forecast by Regions 2018-2023

12.2.1 North America Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.2.2 Europe Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.2.3 Asia-Pacific Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.2.4 South America Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.2.5 Middle East and Africa Benign Prostatic Hyperplasia BPH Drugs Market Forecast 2018-2023

12.3 Benign Prostatic Hyperplasia BPH Drugs Market Forecast by Type 2018-2023

12.3.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales Forecast by Type 2018-2023

12.3.2 Global Benign Prostatic Hyperplasia BPH Drugs Market Share Forecast by Type 2018-2023

12.4 Benign Prostatic Hyperplasia BPH Drugs Market Forecast by Application 2018-2023

12.4.1 Global Benign Prostatic Hyperplasia BPH Drugs Sales Forecast by Application 2018-2023

12.4.2 Global Benign Prostatic Hyperplasia BPH Drugs Market Share Forecast by Application 2018-2023

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source
List of Tables and Figures



Figure Benign Prostatic Hyperplasia (BPH) Drugs Picture

Table Product Specifications of Benign Prostatic Hyperplasia (BPH) Drugs

Figure Global Sales Market Share of Benign Prostatic Hyperplasia (BPH) Drugs by Types in 2017

Table Benign Prostatic Hyperplasia (BPH) Drugs Types for Major Manufacturers

Figure Alpha-Blocker Picture

Figure Phosphodiesterase Type-5 Inhibitors Picture

Figure 5-Alpha-Reductase Inhibitors Picture

Figure Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Applications in 2017

Figure Men Picture

Figure Women Picture

Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure France Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure UK Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure China Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure India Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Benign Prostatic Hyperplasia (BPH) Drugs Revenue (Value) and Growth Rate (2013-2023)

Table Astellas Pharma Basic Information, Manufacturing Base and Competitors

Table Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Astellas Pharma Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Eli Lilly Basic Information, Manufacturing Base and Competitors

Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Eli Lilly Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors

Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table GlaxoSmithKline Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Sanofi Basic Information, Manufacturing Base and Competitors

Table Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Sanofi Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table ADC Therapeutics Basic Information, Manufacturing Base and Competitors

Table ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table ADC Therapeutics Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bayer HealthCare Basic Information, Manufacturing Base and Competitors

Table Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Bayer HealthCare Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors

Table Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Bristol-Myers Squibb Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Valeant Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Valeant Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Endo Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Endo Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Foresee Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Type and Applications

Table Foresee Pharmaceuticals Benign Prostatic Hyperplasia (BPH) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Manufacturer (2016-2017)

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Manufacturer in 2016

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Manufacturer in 2017

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Manufacturer (2016-2017)

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Manufacturer in 2016

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Manufacturer in 2017

Figure Top 3 Benign Prostatic Hyperplasia (BPH) Drugs Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Benign Prostatic Hyperplasia (BPH) Drugs Manufacturer (Revenue) Market Share in 2017

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Regions (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Regions (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Regions (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Regions in 2013

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Regions in 2017

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Countries (2013-2018)

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries (2013-2018)

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries in 2013

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries in 2017

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Countries (2013-2018)

Table North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries (2013-2018)

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2013

Figure North America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2017

Figure United States Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Canada Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Mexico Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales by Countries (2013-2018)

Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries (2013-2018)

Table Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Countries (2013-2018)

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2016

Figure Europe Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2017

Figure Germany Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure UK Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure France Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Russia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Italy Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales by Countries (2013-2018)

Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries 2017

Table Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Countries (2013-2018)

Figure Asia-Pacific Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries 2017

Figure China Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Japan Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Korea Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure India Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Southeast Asia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Sales by Countries (2013-2018)

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries (2013-2018)

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries in 2017

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Countries (2013-2018)

Table South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries (2013-2018)

Figure South America Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2017

Figure Brazil Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Argentina Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Colombia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales by Countries (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales Market Share by Countries in 2017

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Countries (2013-2018)

Table Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2013

Figure Middle East and Africa Benign Prostatic Hyperplasia (BPH) Drugs Revenue Market Share by Countries in 2017

Figure Saudi Arabia Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure UAE Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Egypt Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure Nigeria Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Figure South Africa Benign Prostatic Hyperplasia (BPH) Drugs Sales and Growth Rate (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue by Type (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Revenue Share by Type (2013-2018)

Figure Global Alpha-Blocker Sales Growth (2013-2018)

Figure Global Alpha-Blocker Price (2013-2018)

Figure Global Phosphodiesterase Type-5 Inhibitors Sales Growth (2013-2018)

Figure Global Phosphodiesterase Type-5 Inhibitors Price (2013-2018)

Figure Global 5-Alpha-Reductase Inhibitors Sales Growth (2013-2018)

Figure Global 5-Alpha-Reductase Inhibitors Price (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales by Application (2013-2018)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Share by Application (2013-2018)

Figure Global Women Sales Growth (2013-2018)

Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Sales, Revenue and Growth Rate (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Forecast by Regions (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share Forecast by Regions (2018-2023)

Figure North America Sales Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2023)

Figure Europe Sales Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2023)

Figure Asia-Pacific Sales Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2023)

Figure South America Sales Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2023)

Figure Middle East and Africa Sales Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Forecast by Type (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share Forecast by Type (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Sales Forecast by Application (2018-2023)

Table Global Benign Prostatic Hyperplasia (BPH) Drugs Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List
  Purchase Options for Report

Need More information

Call us :
USA : +1 7162260907
UK : +44 7441952057
....
sales@planetmarketreports.com

Why to PMR

PMR Market Research

Our syndicated research reports cover 50+ industry sectors offering you product and country wise breakup of the market along with niche data and insights that will help you make informed business decision. Our research is focused on the key segments of an industry that possess opportunities of growth.

  • Industrial ...
  • Business ....
  • Consumer ....
  • Peer ....